Integrated Diagnostics Holdings plc IDGXF OTC · Healthcare · Jersey
$0.60 +0.00% +$0.00
Summary
85 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 34% a year over the last 3 years.
- Out of every 100 EGP of revenue, 17 EGP is left as net profit.
- It earns 24 EGP a year on every 100 EGP of invested capital.
- The share price is below the Bulios Fair Price.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.2 EGP for 1 EGP of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (EGP)
Diluted EPS (EGP)
- Analyst estimate
Revenue grew by 24% a year over 5 years. Over the last 3 years it grew by 30% a year. Earnings per share grew by 34% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EGP of revenue goes
- Cost of sales 57 EGP
- Sales and administration 15 EGP
- Taxes and other 11 EGP
- Net profit 17 EGP
Net profit, industry median (Medical - Diagnostics & Research) 9.9 EGP
Out of every 100 EGP of revenue, 17 EGP is left as net profit.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.41%
- Paid out of profit
- 17%
You receive $0.01 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.